进展与生存数据的多状态网络Meta分析
本文提出一种联合网络Meta分析方法,基于时间非齐次三状态(稳定、进展、死亡)马尔可夫模型,用参数生存函数或分数多项式建模时变转移率和相对治疗效果,数据可直接从已发表生存曲线提取,并以非小细胞肺癌试验网络为例演示。
要点
- 提出联合网络Meta分析总生存期与无进展生存期的方法。
- 采用时间非齐次三状态马尔可夫模型建模时变转移率。
- 数据可直接从已发表生存曲线提取,以非小细胞肺癌试验网络演示。
核心结论
- 所提方法可联合合成总生存期与无进展生存期,放宽比例风险假设,扩展至两种以上治疗构成的网络,并简化决策与成本效果分析的参数化。
研究设计与样本
- 方法学论文,提出基于时间非齐次三状态(稳定、进展、死亡)马尔可夫模型的联合网络Meta分析方法。
主要发现
- 用参数生存函数或分数多项式建模时变转移率和相对治疗效果,数据可直接从已发表生存曲线提取。
- 将该方法应用于非小细胞肺癌治疗试验网络进行演示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Here we focus on estimating relative treatment effects for time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). We introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.
引用
- Jansen JP, Incerti D, Trikalinos TA, et al. Multi-state network meta-analysis of progression and survival data. Stat Med. 2023. PMID: 37300446. doi:10.1002/sim.9810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。